NEO Shares Outstanding History
Below is a table of the NEO shares outstanding history going back to 3/24/2010:

Date NEO Shares Outstanding
3/24/201037.26M
4/29/201037.28M
8/9/201037.38M
10/26/201037.41M
2/15/201142.81M
4/26/201142.83M
7/22/201143.09M
10/21/201143.24M
3/8/201244.84M
5/3/201244.87M
8/2/201245.16M
10/30/201245.27M
12/10/201245.27M
2/15/201345.28M
5/6/201348.70M
7/29/201348.89M
10/25/201348.97M
2/18/201449.12M
5/2/201449.68M
7/23/201450.17M
10/31/201459.97M
2/23/201560.26M
4/16/201560.35M
5/5/201560.37M
7/24/201560.51M
11/2/201560.35M
3/9/201675.86M
4/20/201677.12M
8/3/201677.89M
11/2/201678.51M
3/9/201778.82M
5/4/201779.24M
8/3/201779.39M
11/7/201780.41M
3/5/201880.51M
5/4/201880.62M
8/1/201881.64M
11/2/201893.02M
2/22/201994.57M
5/3/201995.34M
8/2/2019103.86M
11/8/2019104.41M
2/24/2020104.83M
4/24/2020105.34M
7/28/2020110.43M
10/27/2020111.03M
2/22/2021116.94M
5/4/2021117.93M
8/5/2021122.82M

Also see: NEO Market Cap History
NEO YTD Return
NEO Historical Shares Outstanding:
+11.06% CAGR
NEO Historical Shares Outstanding: +11.06% CAGR

Mouse over chart for data details
3/24/2010 ...8/5/2021
NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope. We show 49 historical shares outstanding datapoints in our coverage of NEO's shares outstanding history.

Understanding the changing numbers of NEO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NEO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NEO by allowing them to research NEO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for NEO:
NEO SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
NeoGenomics (NEO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NEOG Shares Outstanding History
NEOS Shares Outstanding History
NERV Shares Outstanding History
NK Shares Outstanding History
NKTR Shares Outstanding History
NLNK Shares Outstanding History
NOVN Shares Outstanding History
NSPR Shares Outstanding History
NSTG Shares Outstanding History
NTLA Shares Outstanding History
More Healthcare companies »

 

NEO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.